Newton

Private

Coppell, TexasHealthcare & Life Scienceshttps://neurolens.com/

Last Round

Debt

Dec 5, 2023

Total Funding Raised

$118M

Company Overview

Newton (formerly Neurolens) is a healthcare technology company that develops a vision measurement device system and therapeutic prescription lenses designed to correct eye misalignment and relieve symptoms such as headaches, neck pain, and eye strain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

contoured prism lensesbinocular vision dysfunctioneye misalignmentdigital eye straintherapeutic lensesvision therapymedical deviceoptometry equipmenteye care technologyBVDcustom corrective lenseseye alignment testingheadache reliefclinical practice growth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Newton Comps

Public and private peers based on sector, stage, and business model.

Newton comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Newton Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Dec 5, 2023
Series C	Sep 12, 2022
Series D	Aug 1, 2019
Series B	Dec 15, 2015

View all Funding Rounds

Newton Investors

Notable investors and investment history

Newton investors
Investor	Rounds
Flying L Partners	Series D
Falcon Vision	Series D, Series C
Trinity Capital	Debt
Marshall Wace	Series C
Bluestem Capital	Series B, Series D, Series C
MVM Life Science Partners LLP	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 12, 2022
$67M round led by MVM Life Science Partners LLP.

View all signals

Newton Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Newton Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Newton's valuation, stock price, and market status.

Firmographic Details

HeadquartersCoppell, Texas

Employee Range144

Year Founded2012

Last FundingDec 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.